Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ABPI
Pharma
Pharma industry reaches 'landmark' drug spending deal with UK
The U.K. government has agreed to increase the allowed annual revenue growth rate for branded drugs from 2% in 2024 to 4% by 2027.
Angus Liu
Nov 20, 2023 11:00am
Industry rails against statutory pricing scheme in the UK: ABPI
Oct 17, 2023 3:10pm
AstraZeneca hit by 6 Symbicort marketing rule breaches
Sep 29, 2023 9:20am
Novartis hit with another serious drug marketing breach
Sep 20, 2023 9:55am
Pharma keeps pandemic halo in UK, but pricing is a problem
Aug 31, 2023 8:00am
Novartis slapped with dreaded Clause 2 marketing breach
Jul 12, 2023 9:45am
